Provided by Tiger Trade Technology Pte. Ltd.

Zentalis Pharmaceuticals, LLC

2.63
-0.1450-5.23%
Volume:1.53M
Turnover:4.05M
Market Cap:248.51M
PE:-1.34
High:2.78
Open:2.74
Low:2.60
Close:2.77
52wk High:6.95
52wk Low:1.21
Shares:94.67M
Float Shares:74.83M
Volume Ratio:0.99
T/O Rate:2.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9591
EPS(LYR):-1.9100
ROE:-66.75%
ROA:-33.15%
PB:1.73
PE(LYR):-1.37

Loading ...

Apr 27, 2022

Major Issues Report

8-K - Current report
Apr 11, 2022

Major Issues Report

8-K/A [Amend] - Current report
Apr 11, 2022

Major Issues Report

8-K - Current report
Apr 08, 2022

Major Issues Report

8-K - Current report
Feb 24, 2022

Major Issues Report

8-K - Current report
Feb 24, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 17, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 01, 2021

Major Issues Report

8-K - Current report
Jun 28, 2021

Major Issues Report

8-K - Current report